z-logo
open-access-imgOpen Access
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Author(s) -
Steven Le Gouill,
Catherine Thiéblemont,
Lucie Obéric,
Philippe Moreau,
Krimo Bouabdallah,
Caroline Dartigeas,
Gandhi Damaj,
Thomas Gastinne,
Vincent Ribrag,
Pierre Feugier,
Olivier Casasnovas,
Hacène Zerazhi,
Corinne Haïoun,
Hervé Maisonneuve,
Roch Houot,
Fabrice Jardin,
Éric Van Den Neste,
Olivier Tournilhac,
Katell Le Dû,
Franck Morschhauser,
Guillaume Cartron,
LucMatthieu Fornecker,
Danielle Canioni,
Mary Callanan,
Marie C. Béné,
Gilles Salles,
Hervé Tilly,
T. Lamy,
Rémy Gressin,
Olivier Hermine
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1701769
Subject(s) - mantle cell lymphoma , medicine , rituximab , transplantation , autologous stem cell transplantation , lymphoma , stem cell , surgery , oncology , biology , genetics
International audienc

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom